Filing Details

Accession Number:
0001225208-13-024798
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-05 16:11:36
Reporting Period:
2013-12-05
Filing Date:
2013-12-05
Accepted Time:
2013-12-05 16:11:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385187 Covidien Plc COV Surgical & Medical Instruments & Apparatus (3841) 980624794
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524435 Michael Sgrignari C/O Covidien
15 Hampshire Street
Mansfield MA 02048
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2013-12-05 6,440 $42.39 34,725 No 4 M Direct
Ordinary Shares Acquisiton 2013-12-05 5,712 $39.18 40,437 No 4 M Direct
Ordinary Shares Acquisiton 2013-12-05 5,265 $43.44 45,702 No 4 M Direct
Ordinary Shares Acquisiton 2013-12-05 5,182 $52.53 50,884 No 4 M Direct
Ordinary Shares Acquisiton 2013-12-05 678 $49.48 51,562 No 4 M Direct
Ordinary Shares Disposition 2013-12-05 23,277 $67.33 28,285 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2013-12-05 678 $0.00 678 $49.48
Ordinary Shares Stock Option (Right to Buy) Disposition 2013-12-05 5,265 $0.00 5,265 $43.44
Ordinary Shares Stock Option (Right to Buy) Disposition 2013-12-05 5,712 $0.00 5,712 $39.18
Ordinary Shares Stock Option (Right to Buy) Disposition 2013-12-05 6,440 $0.00 6,440 $42.39
Ordinary Shares Stock Option (Right to Buy) Disposition 2013-12-05 5,182 $0.00 5,182 $52.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,357 2021-06-30 No 4 M Direct
0 2019-11-30 No 4 M Direct
5,713 2020-11-30 No 4 M Direct
12,881 2021-11-30 No 4 M Direct
15,548 2022-12-02 No 4 M Direct
Footnotes
  1. The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $67.32 to $67.37. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
  2. Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
  3. Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.